Marksans Pharma Limited (NSE:MARKSANS)

Marksans Pharma Revenue

Marksans Pharma had revenue of 7.54B INR in the quarter ending December 31, 2025, with 10.64% growth. This brings the company's revenue in the last twelve months to 28.03B, up 13.29% year-over-year. In the fiscal year ending March 31, 2025, Marksans Pharma had annual revenue of 26.23B with 20.46% growth.

• Revenue (ttm): 28.03B
• Revenue Growth: +13.29%
• P/S Ratio: 3.35
• Revenue / Employee: 15.24M
• Employees: 1,840
• Market Cap: 94.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	26.23B	4.45B	20.46%
Mar 31, 2024	21.77B	3.25B	17.56%
Mar 31, 2023	18.52B	3.61B	24.23%
Mar 31, 2022	14.91B	1.15B	8.33%
Mar 31, 2021	13.76B	2.42B	21.32%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 14, 2026

Data Sources Report a data error